STOCK TITAN

Longeveron (NASDAQ: LGVN) shifts reverse split proposal to annual

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Longeveron Inc. cancelled its special meeting of stockholders that had been scheduled for 2026. The company now intends for the previously planned Reverse Stock Split proposal from its March 3, 2026 preliminary proxy statement to be presented instead at its next regularly scheduled annual meeting if it determines this is necessary or advisable.

The filing also includes standard cautionary language that forward-looking statements are subject to risks and uncertainties described in Longeveron’s Annual Report on Form 10-K for the year ended December 31, 2025 and other SEC reports, and notes the company has no obligation to update such statements except as required by law.

Positive

  • None.

Negative

  • None.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
false 0001721484 0001721484 2026-03-23 2026-03-23 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): March 23, 2026

 

Longeveron Inc.

(Exact name of registrant as specified in its charter)

 

Delaware   001-40060   47-2174146
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

1951 NW 7th Avenue, Suite 520

Miami, Florida

  3313
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (305) 909-0840

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, $0.001 par value per share   LGVN   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter)

 

Emerging Growth Company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 

 

Item 8.01. Other Events.

 

On March 23, 2026, Longeveron Inc. (the “Company”) cancelled its special meeting of stockholders scheduled to be held in 2026 (the “Special Meeting”). The Company currently intends for the “Reverse Stock Split” proposal set forth in the preliminary proxy statement relating to the Special Meeting, which was filed with the U.S. Securities and Exchange Commission on March 3, 2026, to instead be presented at the Company’s next regularly scheduled annual meeting of stockholders to the extent the Company determines that it is necessary or advisable to do so.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Current Report on Form 8-K and certain of the materials filed herewith contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, which reflect management’s current expectations, assumptions, and estimates of future operations, performance and economic conditions, and involve known and unknown risks, uncertainties and other important factors that could cause actual results, performance or achievements to differ materially from those anticipated, expressed, or implied by the statements made herein. The forward-looking statements in this Current Report on Form 8-K are made on the basis of the views and assumptions of management regarding future events and business performance as of the date this Current Report on Form 8-K is filed with the SEC. We have based these forward-looking statements largely on our current expectations and projections about our business, the industry in which we operate and financial trends that we believe may affect our business, financial condition, results of operations and prospects, and these forward-looking statements are not guarantees of future performance or development. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that may cause actual events, results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements contained in this Current Report on Form 8-K or the materials furnished or filed herewith.

 

These forward-looking statements are made as of the date of this Current Report on Form 8-K and are subject to a number of risks, uncertainties and assumptions described in greater detail in the Company’s Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission on March 17, 2026, its Quarterly Reports on Form 10-Q, and other filings with the Securities and Exchange Commission. In addition, any forward-looking statements represent the Company’s views only as of today and should not be relied upon as representing its views as of any subsequent date. These statements are inherently uncertain, and the Company disclaims any intention or obligation, other than imposed by law, to update or revise any forward-looking statements, whether as a result of new information, future, events or otherwise occurring after the date this Current Report on Form 8-K is filed.

 

1

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  LONGEVERON INC.
   
Date: March 24, 2026 /s/ Stephen H. Willard
  Name:  Stephen H. Willard
  Title:  Chief Executive Officer

 

2

 

FAQ

What did Longeveron Inc. (LGVN) announce about its 2026 special shareholder meeting?

Longeveron Inc. cancelled its special meeting of stockholders that had been scheduled for 2026. The company disclosed this change in a current report and indicated that related proposals may instead be addressed at its next regularly scheduled annual meeting of stockholders.

What happens to Longeveron’s planned Reverse Stock Split proposal after cancelling the special meeting?

Longeveron currently intends for the Reverse Stock Split proposal, originally included in a March 3, 2026 preliminary proxy for the special meeting, to be presented at its next annual meeting, to the extent the company later determines that doing so is necessary or advisable.

Where was Longeveron’s Reverse Stock Split proposal originally described?

The Reverse Stock Split proposal was originally set forth in Longeveron’s preliminary proxy statement filed on March 3, 2026. That proxy related to the now-cancelled special meeting of stockholders and described the reverse split proposal that may be moved to the annual meeting.

Is Longeveron obligated to update the forward-looking statements in this disclosure?

Longeveron states that its forward-looking statements are made as of the filing date and that it disclaims any intention or obligation to update or revise them, except for any obligations imposed by law in future periods.

Who signed the Longeveron current report relating to the cancelled special meeting?

The current report was signed on behalf of Longeveron Inc. by Stephen H. Willard, Chief Executive Officer. His signature indicates he was the authorized officer executing the disclosure under the Securities Exchange Act of 1934.

Filing Exhibits & Attachments

3 documents
Longeveron Inc

NASDAQ:LGVN

View LGVN Stock Overview

LGVN Rankings

LGVN Latest News

LGVN Latest SEC Filings

LGVN Stock Data

28.49M
20.01M
Biotechnology
Pharmaceutical Preparations
Link
United States
MIAMI